NewGenIvf Group (NIVF) Competitors $2.11 -0.23 (-9.83%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$2.17 +0.06 (+3.08%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends NIVF vs. XGN, TOI, BNR, ENZ, CCM, KDLY, BRTX, MRAI, MGRX, and OPGNShould you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Exagen (XGN), Oncology Institute (TOI), Burning Rock Biotech (BNR), Enzo Biochem (ENZ), Concord Medical Services (CCM), Kindly MD (KDLY), BioRestorative Therapies (BRTX), Marpai (MRAI), Mangoceuticals (MGRX), and OpGen (OPGN). These companies are all part of the "healthcare" industry. NewGenIvf Group vs. Exagen Oncology Institute Burning Rock Biotech Enzo Biochem Concord Medical Services Kindly MD BioRestorative Therapies Marpai Mangoceuticals OpGen Exagen (NASDAQ:XGN) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, community ranking, analyst recommendations, institutional ownership, media sentiment, risk and valuation. Do institutionals & insiders hold more shares of XGN or NIVF? 75.3% of Exagen shares are owned by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are owned by institutional investors. 26.1% of Exagen shares are owned by insiders. Comparatively, 31.8% of NewGenIvf Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is XGN or NIVF more profitable? NewGenIvf Group has a net margin of 0.00% compared to Exagen's net margin of -30.36%. NewGenIvf Group's return on equity of 0.00% beat Exagen's return on equity.Company Net Margins Return on Equity Return on Assets Exagen-30.36% -92.58% -33.74% NewGenIvf Group N/A N/A N/A Which has more risk and volatility, XGN or NIVF? Exagen has a beta of 1.41, indicating that its share price is 41% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of -0.36, indicating that its share price is 136% less volatile than the S&P 500. Does the MarketBeat Community favor XGN or NIVF? Exagen received 23 more outperform votes than NewGenIvf Group when rated by MarketBeat users. CompanyUnderperformOutperformExagenOutperform Votes2357.50% Underperform Votes1742.50% NewGenIvf GroupN/AN/A Do analysts recommend XGN or NIVF? Exagen presently has a consensus price target of $7.50, suggesting a potential upside of 109.50%. Given Exagen's stronger consensus rating and higher probable upside, equities research analysts clearly believe Exagen is more favorable than NewGenIvf Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Exagen 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00NewGenIvf Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has higher valuation & earnings, XGN or NIVF? NewGenIvf Group has lower revenue, but higher earnings than Exagen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExagen$52.55M1.20-$23.69M-$0.94-3.81NewGenIvf Group$5.14M0.21$130KN/AN/A Does the media prefer XGN or NIVF? In the previous week, NewGenIvf Group had 7 more articles in the media than Exagen. MarketBeat recorded 7 mentions for NewGenIvf Group and 0 mentions for Exagen. NewGenIvf Group's average media sentiment score of 0.62 beat Exagen's score of 0.00 indicating that NewGenIvf Group is being referred to more favorably in the news media. Company Overall Sentiment Exagen Neutral NewGenIvf Group Positive SummaryExagen beats NewGenIvf Group on 8 of the 15 factors compared between the two stocks. Get NewGenIvf Group News Delivered to You Automatically Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NIVF vs. The Competition Export to ExcelMetricNewGenIvf Grouphealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.19M$2.07B$5.85B$9.15BDividend YieldN/A7.18%4.76%3.85%P/E RatioN/A11.3616.5114.19Price / Sales0.217.45450.0276.60Price / Cash3.119.3238.0134.95Price / Book0.964.547.644.63Net Income$130,000.00$87.49M$3.18B$245.69M7 Day Performance8.21%-2.59%-1.95%-2.68%1 Month Performance-61.08%-6.14%-0.23%-2.16%1 Year PerformanceN/A-23.95%16.69%12.90% NewGenIvf Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NIVFNewGenIvf Group2.28 of 5 stars$2.11-9.8%N/AN/A$1.19M$5.14M0.00N/ANews CoverageGap DownXGNExagen4.3306 of 5 stars$4.23-0.9%$7.50+77.3%+77.2%$74.61M$55.75M-4.50220TOIOncology Institute2.3995 of 5 stars$0.96+5.9%$2.50+160.1%-51.6%$72.62M$378.93M-1.23660News CoverageBNRBurning Rock Biotech0.6442 of 5 stars$6.94+13.0%N/A-17.7%$71.07M$75.70M-2.311,390Gap UpHigh Trading VolumeENZEnzo Biochem1.5029 of 5 stars$0.54+5.9%N/A-61.2%$28.21M$31.91M0.00520Analyst ForecastNews CoverageCCMConcord Medical Services0.6092 of 5 stars$4.77-1.6%N/A-36.2%$20.70M$75.69M0.00970Analyst ForecastNews CoverageGap DownKDLYKindly MDN/A$2.89+15.6%N/AN/A$17.28MN/A0.00N/AHigh Trading VolumeBRTXBioRestorative Therapies3.1628 of 5 stars$2.29-6.9%$18.00+686.0%+32.0%$15.85M$150,000.00-1.507News CoverageMRAIMarpaiN/A$0.91-1.1%$6.00+559.3%-33.0%$13.18M$34.87M-0.34150Gap DownMGRXMangoceuticals0.813 of 5 stars$4.84+9.3%N/A-91.2%$12.04M$755,000.00-0.843News CoverageGap UpOPGNOpGenN/A$1.38+0.7%N/A-70.2%$11.54M$3.42M0.00100Analyst Forecast Related Companies and Tools Related Companies Exagen Alternatives Oncology Institute Alternatives Burning Rock Biotech Alternatives Enzo Biochem Alternatives Concord Medical Services Alternatives Kindly MD Alternatives BioRestorative Therapies Alternatives Marpai Alternatives Mangoceuticals Alternatives OpGen Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NIVF) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewGenIvf Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NewGenIvf Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NIVF Stock Alerts